comprehensive -WSS

comprehensive

author：explore 2025-10-01 10:57:55 - browse：9559

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Medicare to cover more brain scans for Alzheimer’s patients

hotspot

focus

WSS

Videos point to link between seizures and unexplained toddler deaths

Morgan Health, with ambitious aims, wants you to know it’s still here

Listen: Wegovy in the brain & pivotal Alzheimer's data

JPM: CVS says Medicare Advantage patients are impacting profits

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Wikipedia

comprehensive

entertainment

Affirmative action in medical school literally saved lives

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

3 medical device trends to watch in 2024

The cancer drug shortage isn’t new — and neither are the solutions

Sanders adds drug shortage policies to pandemic preparedness bill

Alkermes shareholders re

Why psychiatrists like me stop taking insurance

Cancer drug shortages should be causing more outrage

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

hotspot

Sanofi seeks simpler, safer CRISPR sickle cell cure

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

How Medicaid coverage policies for immigrants impact new moms

Why psychiatrists like me stop taking insurance

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

AI can’t replace a physician’s gut feeling

hotspot

focus

Wikipedia

knowledge